Replies to post #741358 on NorthWest Biotherapeutics Inc (NWBO)

[georgebailey]

Dstock what I think I learned is that GSVA analysis is used to create scores. This scoring system then permits the breakdown of a particular cancer type into subgroups. Now that we have subgroups we can identify what L should be combined with. This is the backbone of the entire L franchise.

As a layman, cancers will be scored via gsva. The scoring system can then be used to prescribe a treatment course.
Do I have the concept?

[beartrap12]

dstock, As far as the replacement for BCG... I don't think Linda will want to get her ingredients for DCVax from a competing BP. If she does, she's beholden to them unless she's able to write an ironclad legal agreement that will keep them from taking over NWBO and DCVax or advantage of us. I don't see her taking that chance. Instead, I think she'll get the BCG-replacement from a small company or in-service it from a university, as she's done before. I would not be surprised to hear she's already penned an agreement with a company for a BCG replacement and I hope we hear about it soon after MHRA decision. Other possibilities include merging with the company/companies that have poly-iclc and IL-7 and the BCG replacement. I personally like that idea because it could give us a chance to jump to a real stock market with a new sticker name and burn the shorts.
Remember, Les said on Big Biz we would not recognize the company by fall. (Merger/Name change maybe??) Of course, he was off on the timing.
So the way I see his comment, something big is coming soon!